| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 25 | XLO Xilio Therapeutics | Common stock | Sell | Dispose S | No | Yes | 0.9837 | 1,803 | 1.77 k | 3,197 |
| 1 Jan 25 | XLO Xilio Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 5,000 | 0.00 | 5,000 |
| 1 Jan 25 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.955 | 60,000 | 57.30 k | 60,000 |
| 1 Jan 25 | XLO Xilio Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 5,000 | 0.00 | 15,000 |
| 1 Oct 24 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.75 | 26,000 | 19.50 k | 26,000 |
| 1 May 24 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.08 | 20,000 | 21.60 k | 20,000 |
| 1 Jan 24 | XLO Xilio Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 20,000 |
| 16 Aug 23 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.785 | 25,000 | 69.63 k | 25,000 |
